Connection

ALASTAIR THOMPSON to Disease-Free Survival

This is a "connection" page, showing publications ALASTAIR THOMPSON has written about Disease-Free Survival.
Connection Strength

0.169
  1. Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study. Br J Cancer. 2014 Feb 04; 110(3):565-72.
    View in: PubMed
    Score: 0.048
  2. Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer. Br J Cancer. 2012 Feb 28; 106(5):955-61.
    View in: PubMed
    Score: 0.043
  3. Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy. Breast Cancer Res Treat. 2011 Jan; 125(1):279-87.
    View in: PubMed
    Score: 0.039
  4. NT5E CpG island methylation is a favourable breast cancer biomarker. Br J Cancer. 2012 Jun 26; 107(1):75-83.
    View in: PubMed
    Score: 0.011
  5. The impact of operative approach for oesophageal cancer on outcome: the transhiatal approach may influence circumferential margin involvement. Eur J Surg Oncol. 2012 Feb; 38(2):157-65.
    View in: PubMed
    Score: 0.011
  6. Avoidance of CYP2D6 inhibitors in patients receiving tamoxifen. J Clin Oncol. 2010 Oct 10; 28(29):e584-5; author reply e586.
    View in: PubMed
    Score: 0.010
  7. A candidate molecular signature associated with tamoxifen failure in primary breast cancer. Breast Cancer Res. 2008; 10(5):R88.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.